Bellecapital’s Sanofi SNY Stock Holding History

Bellecapital’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-5,475	Closed	-$279K	–	169
2020 Q2	$279K	Sell	5,475 -1,575	-22%	-$76.5K	0.13%	114
2020 Q1	$308K	Sell	7,050 -2,000	-22%	-$95.7K	0.2%	95
2019 Q4	$454K	Hold	9,050	–	–	0.23%	88
2019 Q3	$419K	Hold	9,050	–	–	0.25%	82
2019 Q2	$392K	Hold	9,050	–	–	0.24%	82
2019 Q1	$401K	Buy	9,050 +825	+10%	+$35.3K	0.26%	73
2018 Q4	$357K	Buy	+8,225	New	+$363K	0.25%	67
2018 Q3	–	Sell	-7,340	Closed	-$294K	–	95
2018 Q2	$294K	Hold	7,340	–	–	0.21%	69
2018 Q1	$294K	Hold	7,340	–	–	0.28%	68
2017 Q4	$316K	Hold	7,340	–	–	0.26%	62
2017 Q3	$365K	Hold	7,340	–	–	0.43%	47
2017 Q2	$352K	Hold	7,340	–	–	0.31%	48
2017 Q1	$332K	Buy	+7,340	New	+$311K	0.31%	51

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Bellecapital's SNY Position: Q3 2020 in Review

Bellecapital sold out of Sanofi (SNY) in Q3 2020, closing a stake of 5,475 shares — an estimated $279K sold.

Bellecapital first reported a position in SNY in Q1 2017 and held it in 13 quarters. The position peaked at $454K in Q4 2019. 573 funds tracked by Wall St. Rank hold SNY as of Q3 2020.

Bellecapital reported no remaining Sanofi position as of Q3 2020 after selling out during the quarter.
Bellecapital sold 5,475 Sanofi shares in Q3 2020, an estimated $279K.
Bellecapital first reported a position in Sanofi in Q1 2017 and held it in 13 quarters.
Bellecapital's Sanofi position peaked at $454K in Q4 2019.
573 funds tracked by Wall St. Rank held Sanofi as of Q3 2020.

Based on Bellecapital's 13F filing for Q3 2020, filed 16 Oct 2020.